Key facts
- This page summarizes Kate Rochlin's Form 3 filing for IN8BIO, INC. (INAB).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 10 Dec 2021, 15:41.
Kate Rochlin - 01 Dec 2021 Form 3 Insider Report for IN8BIO, INC. (INAB)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- INAB
- Reported as of
- 01 Dec 2021
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 10 Dec 2021, 15:41:38 UTC
- Next SEC filing
- 17 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jason Minio, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kate Rochlin filed Form 3 for IN8BIO, INC. (INAB) on 10 Dec 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INAB
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 46,984
- Exercise price
- $6.74
- Footnotes
- F1
INAB
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 41,616
- Exercise price
- $5.36
- Footnotes
- F2
INAB
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 35,000
- Exercise price
- $10.00
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Twenty-five percent (25%) of the shares subject to the option vested on October 1, 2021 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
Footnote F2
Twenty-five percent (25%) of the shares subject to the option shall vest on February 1, 2022 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
Footnote F3
One forty-eighth (1/48th) of the shares subject to the option shall vest monthly commencing on August 29, 2021, subject to the Reporting Person continuing to provide service through each such date.
SEC remarks
Exhibit List - Exhibit 24 - Power of Attorney